VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
NHI
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
NHINational Health Investors, Inc.
$77.55$3.8B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksNHIFinancials

National Health Investors, Inc. (NHI) Financials

30Y historyFree accessUpdated daily

Revenue growth accelerated to 29.7% in 2026Q1, though this was accompanied by a sharp contraction in NOI margins to 31.1% compared to historical levels near 96%.

NHI Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Revenue402.91M378.53M335.18M319.83M278.19M298.71M332.81M318.08M294.61M278.66M248.5M228.99M177.51M117.83M96.95M82.7M78.4M64.22M63.01M62.31M150.72M157.38M155.56M162.49M171.78M139.17M147.51M131.16M102.29M110.18M99.43M
Revenue Growth %17.48%12.93%4.8%14.97%-6.87%-10.24%4.63%7.97%5.72%12.14%8.52%29%50.65%21.53%17.23%5.49%22.07%1.93%1.11%-58.66%-4.23%1.17%-4.27%-5.41%23.43%-5.66%12.47%28.22%-7.16%10.81%13.12%
Property Operating Expenses156.08M239.6M11.16M11.51M9.79M11.64M9.65M5.8M1.17M960K1.01M985K620K616K771K02M00000000000000
Net Operating Income (NOI)246.83M138.93M324.02M308.32M268.41M287.08M323.16M312.28M293.45M277.7M247.49M228M176.89M117.21M96.18M82.7M76.39M64.22M63.01M62.31M150.72M157.38M155.56M162.49M171.78M139.17M147.51M131.16M102.29M110.18M99.43M
NOI Margin %61.26%36.7%96.67%96.4%96.48%96.1%97.1%98.18%99.6%99.66%99.59%99.57%99.65%99.48%99.2%100%97.44%100%100%100%100%100%100%100%100%100%100%100%100%100%100%
Operating Expenses51.44M-55.9M140.16M129.53M135.64M101.83M98.24M92.27M85.37M80.84M70.77M65.13M48.01M30.75M25.91M20.84M19.9M14.58M13.73M8.01M100.5M120.98M99.73M105.03M129.67M119.13M85.25M103.14M51.76M57.01M52.9M
G&A Expenses13.66M021.79M19.82M25.32M19.34M14.56M13.91M12.86M12.71M10.2M10.98M9.32M10.04M8.56M8.03M8.85M7.21M5.18M5.66M5.34M4.31M3.49M3.13M2.43M3.3M3.46M3.27M3.89M3.7M3.69M
EBITDA282.32M278.67M255.3M248.76M203.65M266.05M308.07M296.83M299.03M277.78M263.85M217.02M146.88M97.94M87.62M73.86M69.48M58.26M57.22M66.03M62.03M49M70.28M72.84M58.49M34.7M76.44M39.51M59.49M61.2M53.36M
EBITDA Margin %70.07%73.62%76.17%77.78%73.2%89.06%92.57%93.32%101.5%99.68%106.18%94.77%82.75%83.13%90.37%89.3%88.63%90.72%90.81%105.96%41.16%31.14%45.18%44.83%34.05%24.93%51.82%30.12%58.16%55.55%53.67%
Depreciation & Amortization86.93M83.84M71.44M69.97M70.88M80.8M83.15M76.82M89.79M79.96M86.12M53.16M40.69M20.1M16.58M11.99M10.99M8.62M7.94M11.72M11.81M12.6M14.45M15.38M16.38M14.66M14.17M11.48M8.96M8.04M6.83M
D&A / Revenue %21.57%22.15%21.31%21.88%25.48%27.05%24.98%24.15%30.48%28.7%34.66%23.22%22.92%17.06%17.1%14.5%14.01%13.42%12.61%18.82%7.83%8.01%9.29%9.47%9.54%10.53%9.61%8.76%8.75%7.29%6.87%
Operating Income195.39M194.83M183.86M178.79M132.77M185.25M224.92M220.01M209.24M197.81M177.73M163.86M106.19M77.84M71.04M61.86M58.5M49.64M49.27M54.3M50.23M36.4M55.83M57.46M42.11M20.04M62.26M28.02M50.53M53.17M46.53M
Operating Margin %48.49%51.47%54.85%55.9%47.72%62.02%67.58%69.17%71.02%70.99%71.52%71.56%59.82%66.07%73.27%74.8%74.62%77.3%78.2%87.14%33.32%23.13%35.89%35.36%24.51%14.4%42.21%21.37%49.4%48.26%46.8%
Interest Expense3M57.37M56.12M55.51M42.44M48.11M056.3M49.05M043.11M009.23M3.49M3.85M1.55M85K308K4.63M00000000000
Interest Coverage-3.45x3.43x3.42x2.54x3.33x-3.80x4.08x-4.48x--9.48x21.77x16.65x40.81x575.91x147.40x15.38x-----------
Non-Operating Income-6.9M-3.33M-8.86M-11.1M24.91M25.11M-9.93M6.04M4.2M-4.05M34.55M89.51M3.14M20.59M-1.34M-2.19M-845K9.18M10.05M00019.48M00000000
Pretax Income146.72M140.79M136.59M134.38M65.41M112.03M185.31M160.45M154.33M159.37M153.47M149.61M103.05M79.5M74.66M81.13M69.42M64.23M57.51M67.64M62.95M53.71M67.52M047.19M000000
Pretax Margin %36.42%37.19%40.75%42.02%23.51%37.5%55.68%50.44%52.39%57.19%61.76%65.33%58.05%67.47%77.01%98.1%88.55%100.01%91.28%108.55%41.76%34.13%43.41%0%27.47%0%0%0%0%0%0%
Income Tax00-45K0-89K66K00-9.17M0749K-707K24.67M-17.13M-12.53M-19.27M-10.92M-14.59M-8.24M-42.13M-18.83M-17.65M-472K13.66M11.83M21.19M29.7M-24.85M-18.42M-22.22M-19.52M
Effective Tax Rate %0%0%-0.03%0%-0.14%0.06%0%0%-5.94%0%0.49%-0.47%23.94%-21.55%-16.78%-23.75%-15.73%-22.71%-14.32%-62.29%-29.92%-32.86%-0.7%-25.08%------
Net Income148.11M142.18M137.99M135.65M66.4M111.8M185.13M160.46M154.33M159.37M151.54M148.86M101.61M106.18M90.73M81.13M69.42M64.23M57.51M96.44M69.23M54.41M56.38M43.81M30.79M-63K33.72M53.62M69.64M75.39M67.16M
Net Margin %36.76%37.56%41.17%42.41%23.87%37.43%55.62%50.45%52.39%57.19%60.98%65.01%57.24%90.12%93.58%98.1%88.55%100.01%91.28%154.76%45.93%34.57%36.24%26.96%17.92%-0.05%22.86%40.88%68.08%68.42%67.55%
Net Income Growth %4.89%3.04%1.72%104.29%-40.61%-39.61%15.37%3.97%-3.16%5.16%1.8%46.5%-4.31%17.03%11.83%16.87%8.08%11.68%-40.36%39.3%27.24%-3.5%28.7%42.29%48968.25%-100.19%-37.1%-23.01%-7.62%12.24%35.14%
Funds From Operations (FFO)235.04M226.02M209.43M205.63M137.28M192.6M268.28M237.27M244.12M239.33M237.66M202.03M142.3M126.28M107.31M93.12M80.41M72.85M65.45M108.16M81.04M67.01M70.83M59.19M47.17M14.6M47.9M65.1M78.6M83.42M74M
FFO Margin %58.34%59.71%62.48%64.29%49.35%64.48%80.61%74.59%82.86%85.89%95.64%88.23%80.16%107.18%110.68%112.6%102.57%113.44%103.89%173.58%53.77%42.58%45.53%36.43%27.46%10.49%32.47%49.64%76.84%75.72%74.42%
FFO Growth %41.27%7.92%1.85%49.78%-28.72%-28.21%13.07%-2.81%2%0.7%17.64%41.97%12.68%17.68%15.23%15.82%10.37%11.3%-39.48%33.47%20.93%-5.39%19.67%25.48%223.19%-69.53%-26.43%-17.17%-5.78%12.74%32.61%
FFO per Share4.844.804.754.743.064.216.005.435.805.826.075.374.264.453.853.352.902.642.363.892.922.412.572.191.760.601.952.672.743.312.72
FFO Payout Ratio %54.7%75.08%74.73%75.98%117.84%94.96%72.53%75.75%67.75%63.95%58.19%61.7%70.73%67.42%73.55%72.91%82.73%88.61%130.66%62.35%64.84%79.48%68.68%72.65%87.14%12.89%106.6%113.3%96.39%88.2%87.15%
EPS (Diluted)3.053.023.133.130.511.363.032.383.673.873.873.953.043.743.262.922.502.322.073.472.491.962.031.571.10-0.001.312.132.692.922.80
EPS Growth %-1.59%-3.51%0%513.73%-62.5%-55.12%27.31%-35.15%-5.17%0%-2.03%29.93%-18.72%14.72%11.64%16.8%7.76%12.08%-40.35%39.36%27.04%-3.45%29.3%42.73%--100.2%-38.5%-20.82%-7.88%4.29%12.45%
EPS (Basic)-3.033.143.130.521.363.032.403.683.903.883.963.043.743.262.932.512.332.083.482.501.962.051.581.10-0.001.312.132.723.012.92
Diluted Shares Outstanding48.55M47.05M44.1M43.39M44.79M45.73M44.7M43.7M42.09M41.15M39.16M37.64M33.42M28.4M27.84M27.79M27.73M27.62M27.73M27.78M27.78M27.83M27.53M26.99M26.85M24.47M24.56M24.37M28.69M25.17M27.24M

Key Metrics

Growth RegimeAccelerating
ProfitabilityModerate
Balance SheetHealthy
Cash FlowRobust
Top Statement Risk

Operator concentration and labor

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Revenue Expansion Amid Portfolio Shifts

As reported in recent financial statements, NHI achieved a notable 29.7% revenue growth in 2026Q1, signaling a potential acceleration in top-line performance that warrants further investigation into whether this is driven by organic occupancy gains or the recent strategic transition of assets into the SHOP structure.

The sharp revenue increase suggests that the company is successfully capturing more gross resident fees through its operating portfolio. However, investors should monitor if this growth is sustainable or merely an accounting byproduct of shifting from triple-net lease structures to more operationally intensive joint ventures.

NOI Margin Compression Signals Risk

Based on the provided quarterly data, the NOI margin experienced a significant contraction to 31.1% in 2026Q1, down from the historical stability of approximately 96% observed in previous periods, which may indicate rising labor and operating costs within the newly integrated SHOP assets.

This margin volatility appears to confirm the inherent risks of moving away from a pure-play triple-net model toward an operating portfolio. The sharp decline suggests that the company is now absorbing property-level expenses that were previously the responsibility of tenants, potentially impairing overall profitability.

FFO Growth Outpacing Historical Trends

According to the company's reported figures, FFO reached $64.5 million in 2026Q1, representing a 21.0% growth rate that suggests a strong recovery in earnings quality despite the recent operational shifts occurring within the broader senior housing portfolio managed by the firm.

The trajectory of FFO per share indicates that management is successfully navigating the transition to a more complex operating model. Nevertheless, the divergence between FFO and AFFO suggests that recurring maintenance capital expenditures remain a critical factor that could impact future dividend coverage and cash flow stability.

Operational Complexity Challenges Earnings Quality

Analysis of the income statement reveals that the recent surge in revenue is accompanied by a disproportionate decline in NOI margins, suggesting that the company's pivot to SHOP structures may be masking underlying operational inefficiencies that could threaten long-term cash flow predictability for shareholders.

The transition from fixed rental income to variable operating revenue introduces significant exposure to labor inflation and occupancy volatility. Investors should be cautious, as this shift may lead to earnings quality degradation if the company cannot effectively manage the increased overhead associated with its senior housing facilities.

NHI — Frequently Asked Questions

Quick answers to the most common questions about buying NHI stock.

What was National Health Investors, Inc.'s (NHI) revenue in 2025?

For fiscal year 2025, National Health Investors, Inc. (NHI) reported total revenue of $378.5M. This represents a 280.7% increase compared to $99.4M in 1996.

Is National Health Investors, Inc. (NHI) profitable?

National Health Investors, Inc. (NHI) is profitable, generating $142.2M in net income for the fiscal year ending 2025 with a net profit margin of 37.6%.

What is National Health Investors, Inc.'s operating profit margin?

National Health Investors, Inc. (NHI) reported an operating income of $194.8M, resulting in an operating profit margin of 51.5%. This margin reflects the operational efficiency of the business before interest and taxes.

What is National Health Investors, Inc.'s gross profit and gross margin?

National Health Investors, Inc. (NHI) generated $138.9M in gross profit for the year, representing a gross profit margin of 36.7%. This demonstrates the company's core pricing power and production efficiency.